Megalis
Megalis
- In our pharmacy you can buy megalis without a prescription, with delivery across Australia (discreet packaging and typical delivery in 5–14 days).
- Megalis (tadalafil) is used to treat erectile dysfunction and benign prostatic hyperplasia; the same active ingredient is also used (as Adcirca) for pulmonary arterial hypertension. It is a phosphodiesterase‑5 (PDE5) inhibitor that increases cyclic GMP, relaxing smooth muscle and improving blood flow to the penis and pulmonary vasculature.
- Usual doses: for ED as needed 10–20 mg before sexual activity or 2.5–5 mg once daily; for BPH 5 mg once daily; for PAH (Adcirca) 40 mg daily (2 × 20 mg).
- Form of administration: oral tablet (available in 2.5 mg, 5 mg, 10 mg and 20 mg strengths; Megalis commonly sold as 5 mg, 10 mg and 20 mg blister packs).
- Onset time: most men notice an effect within about 30–60 minutes (some may require up to 2 hours); tadalafil can be effective when taken well before sexual activity.
- Duration of action: a single dose can work for up to 36 hours; daily dosing provides continuous effect while taken regularly.
- Alcohol warning: avoid excessive alcohol—drinking large amounts can increase dizziness and low blood pressure and may reduce erectile response; moderate alcohol may still cause adverse effects when combined with tadalafil.
- The most common side effect is headache; other frequent effects include flushing, indigestion, nasal congestion, back pain and muscle aches (rare but serious effects include prolonged erection, sudden vision or hearing loss — seek urgent care).
- Would you like to try “megalis” without a prescription?
Latest Research Highlights — Australian And International (2022–Mid‑2024)
Basic Megalis Information
- INN (International Nonproprietary Name): Tadalafil
- Brand Names Available In Australia: Megalis (Macleods), Cialis (Eli Lilly), Adcirca (PAH formulation)
- ATC Code: G04BE08
- Forms & Dosages: Tablets 2.5 mg, 5 mg, 10 mg, 20 mg (most common Megalis tablets 5 mg, 10 mg, 20 mg in blister packs of 4–10)
- Manufacturers In Australia: Not specified
- Registration Status In Australia: Not specified
- OTC / Rx Classification: Prescription Only (Rx only in nearly all markets)
Latest Research Highlights — Australian And International (2022–Mid‑2024)
Clinicians and patients ask whether tadalafil still holds up in recent trials and reviews.
New trials and meta‑analyses through mid‑2024 confirm tadalafil’s established efficacy for erectile dysfunction and symptomatic benign prostatic hyperplasia.
Evidence continues to support tadalafil’s use in pulmonary arterial hypertension under the Adcirca brand for PAH indications.
Pharmacokinetics matter: tadalafil’s longer half‑life (around 17.5 hours) gives a prolonged 24–36‑hour therapeutic window compared with shorter‑acting sildenafil.
Low‑dose daily regimens (2.5–5 mg) show improvements in penile responsiveness and in lower urinary tract symptoms in men with BPH in pooled analyses.
Head‑to‑head trials show broadly similar efficacy to other PDE5 inhibitors while differing in onset and adverse‑effect profiles.
Pharmacovigilance datasets in high‑income settings keep listing the now‑expected mild adverse effects of headache, flushing and myalgia or back pain.
Rare but serious events such as priapism and sudden visual or hearing changes remain part of surveillance warnings.
| Outcome | Evidence Summary | Clinical Note |
|---|---|---|
| Erectile Dysfunction Efficacy | Consistent improvement in erectile function scores vs placebo in RCTs and meta‑analyses. | Daily low‑dose option and on‑demand 10–20 mg both effective. |
| BPH / LUTS | Symptom reduction with 5 mg daily in several trials and pooled analyses. | Useful when LUTS coexists with ED. |
| PAH | Adcirca (tadalafil 20 mg tablets, total 40 mg/day) shows benefit in functional class and exercise tolerance. | Used under specialist supervision and subsidy pathways. |
| Safety Profile | Common: headache, flushing, dyspepsia, back pain. Rare: priapism, sudden vision/hearing loss. | Monitor cardiovascular status and drug interactions, especially nitrates. |
Data Highlight: TGA adverse‑drug‑reaction trends align with international reporting: headaches and flushing predominate while serious events remain rare.
Clinical Effectiveness In Australia — Real‑World Outcomes And Regulatory Monitoring
Patients in Australia want to know how tadalafil performs outside trials.
In Australian clinics and audits, tadalafil—sold as branded Cialis and generics including Megalis—shows sustained patient satisfaction when treatment is matched to need.
Once‑daily dosing for BPH and low‑dose daily regimens for ED are popular with men seeking spontaneity or frequent activity.
The Therapeutic Goods Administration monitors adverse events via the Database of Adverse Event Notifications, and routine TGA signals mirror international safety profiles.
PBS coverage in Australia is limited and varies by indication, so most ED prescribing happens privately while PAH and specific pathways may be subsidised.
Australian prescribers routinely screen cardiovascular risk, reconcile nitrates and other interactions, and check renal and hepatic function before starting tadalafil.
Telehealth plus community pharmacy pathways are common for repeat supply and counselling in urban and regional settings.
| Regulator / Payer | Typical Status | Usual Clinic Pathway |
|---|---|---|
| TGA | Monitors safety via DAEN | Report ADRs; routine pharmacovigilance |
| PBS | Limited subsidy for ED; PAH pathways may be covered | Private scripts for ED; specialist scripts for PAH |
| Community Pharmacy | Stocks branded and generic supplies | Telehealth prescription collection, counselling |
Indications And Expanded Uses — TGA‑Approved And Off‑Label Practice
People often ask what tadalafil is officially approved to treat and where clinicians use it off‑label.
- Labelled Indications: Erectile dysfunction and benign prostatic hyperplasia (BPH).
- PAH: Tadalafil is available as Adcirca for pulmonary arterial hypertension under the PAH label.
- Off‑Label Uses: Low‑dose trials for mixed LUTS/ED, combination therapy with alpha‑blockers under monitoring, and small investigational studies in vascular microcirculation disorders.
| Indication | Typical Adult Dose |
|---|---|
| Erectile Dysfunction (ED) | As needed 10–20 mg before activity; or 2.5–5 mg once daily |
| Benign Prostatic Hyperplasia (BPH) | 5 mg once daily |
| Pulmonary Arterial Hypertension (PAH; Adcirca) | 40 mg once daily (2 × 20 mg) |
Contraindicated co‑uses such as nitrates and use in children restrict broader adoption.
Composition And Brand Landscape — Active Ingredient, Packaging And Suppliers
Shoppers want to know what’s inside the pack and who makes it.
The active ingredient is tadalafil, International Nonproprietary Name (INN).
Megalis is manufactured by Macleods Pharmaceuticals Ltd in India and is commonly supplied as 5 mg, 10 mg and 20 mg tablets in blister packs of 4–10 tablets.
Cialis from Eli Lilly is available worldwide in 2.5–20 mg tablets, and Adcirca is supplied as 20 mg tablets typically in bottles of 56 or 60 for PAH use.
In Australia the market includes registered branded and generic tadalafil products and some imported generics distributed via wholesalers and pharmacies.
| Brand | Manufacturer | Pack Sizes & Strengths | Regulatory Note |
|---|---|---|---|
| Megalis | Macleods Pharmaceuticals (India) | 5 mg, 10 mg, 20 mg; blister packs (usually 4–10) | Generic; commonly imported |
| Cialis | Eli Lilly | 2.5 mg, 5 mg, 10 mg, 20 mg; blister strips or bottles | Branded product |
| Adcirca | Eli Lilly | 20 mg; bottles (56/60) | PAH formulation; used under specialist care |
Price‑sensitive consumers in Australia often compare generics and branded options at major retailers and online sellers.
Contraindications And Special Precautions — High‑Risk Groups In Australia
Safety is the first question for many patients and prescribers.
- Absolute Contraindications: Concurrent nitrate therapy, known hypersensitivity to tadalafil or excipients, and use in children.
- Relative Contraindications: Unstable cardiovascular disease, recent myocardial infarction or stroke, significant hypotension or uncontrolled hypertension, severe renal or hepatic impairment, and conditions predisposing to priapism.
Special Australian considerations include the higher prevalence of cardiometabolic disease in some Aboriginal and Torres Strait Islander communities, which increases the need for cardiovascular screening before prescribing.
Remote patients should be counselled about rare serious events and the local emergency access plan before starting therapy.
Daily‑life advice includes avoiding heavy alcohol when dosing and not driving if feeling dizzy or experiencing visual disturbance.
| Risk | Action |
|---|---|
| Concurrent Nitrates | Do Not Prescribe; contraindicated due to severe hypotension risk |
| Severe Renal/Liver Impairment | Consider dose reduction or avoid use |
| High Cardiovascular Risk | Obtain clearance from cardiology or manage risk factors first |
Dosage Guidelines — Standard Regimens And Adjustments In Australia
Patients ask how much to take and when.
Adult dosing follows product information: ED as‑needed 10–20 mg before sexual activity (no more than once daily) or daily 2.5–5 mg for continuous use.
BPH is treated with tadalafil 5 mg once daily.
PAH under the Adcirca label is dosed at 40 mg once daily (two 20 mg tablets).
Adjustments: in mild to moderate renal impairment use lower doses and avoid use in severe renal impairment.
In mild to moderate liver impairment start at the lowest dose; avoid use in severe hepatic impairment.
Elderly patients do not require automatic dose reduction but need assessment for comorbidities and polypharmacy.
| Indication | Standard Dose | Adjustment Notes |
|---|---|---|
| ED (On‑Demand) | 10–20 mg before activity | Max once daily |
| ED (Daily) | 2.5–5 mg once daily | Useful for frequent activity |
| BPH | 5 mg once daily | Ongoing therapy |
| PAH (Adcirca) | 40 mg once daily (2×20 mg) | Specialist prescribing |
Missed doses for daily regimens should be taken when remembered but not doubled.
In suspected overdose seek urgent medical attention for symptoms such as hypotension, syncope or priapism.
Interactions Overview — Medicines, Food And Reporting Via TGA/E‑Health
Interactions are a common concern at the pharmacy counter.
Major interactions include nitrates, which are an absolute contraindication due to the risk of severe hypotension.
Strong CYP3A4 inhibitors like ritonavir or ketoconazole increase tadalafil levels and may require dose reduction or avoidance.
Alpha‑blockers can cause symptomatic hypotension when combined with tadalafil; start at low doses and monitor blood pressure.
Grapefruit juice is a weaker CYP3A4 interaction but caution is sensible.
Alcohol increases dizziness and hypotension risk, so avoid heavy drinking around dosing.
| Drug/Class | Effect | Action |
|---|---|---|
| Nitrates | Marked hypotension | Contraindicated — do not co‑prescribe |
| Strong CYP3A4 Inhibitors | Increased tadalafil levels | Consider dose reduction or avoid |
| Alpha‑Blockers | Risk of symptomatic hypotension | Initiate low dose and monitor |
| Herbal ED Products | Unknown contents; risk of undeclared PDE5 inhibitors | Advise verification and caution |
Report suspected interactions and adverse events to the TGA via DAEN, and use My Health Record or e‑prescribing notes to help reconcile medicines across telehealth and community pharmacy systems.
Cultural Perceptions And Patient Habits In Australia — Stigma, Access And Telehealth
Many people are embarrassed to talk about ED and look for private routes to treatment.
Telehealth services and online pharmacies have grown in popularity for discreet consultations and e‑prescriptions.
Price sensitivity leads shoppers to compare generics like Megalis at major retailers and online sellers.
Rural and remote patients balance trust in local GPs and pharmacists against long travel times to urology or sexual health clinics.
Indigenous men may face additional barriers including stigma, limited culturally safe services, and higher cardiometabolic risk that requires careful assessment before prescribing.
Community pharmacists — in chains and independents — play a key role in pragmatic counselling, referral and safe sourcing advice.
In our online pharmacy, Megalis is available without a prescription, with discreet delivery to Australia in 5‑14 days.
Availability And Pricing Patterns — Pharmacies, Online Sellers And PBS Considerations
Access and cost are top of mind when people shop for tadalafil products.
Branded and generic tadalafil, including imported Megalis packs, are stocked by Australian retail pharmacies and online wholesalers.
Major chains advertise competitive pricing and telehealth providers commonly link e‑prescriptions to same‑day collection or mail order.
PBS subsidisation is limited for ED, so most ED treatment is paid privately while PAH (Adcirca) may be accessed via PBS or state pathways in selected cases.
| Source | Typical Price Pattern | Notes |
|---|---|---|
| Retail Pharmacy (Chains) | Competitive for generics | In‑store collection and counselling |
| Online Sellers / Import | Often lower unit price | Pharmacist should check authenticity; risk of counterfeit imports |
| PBS | Limited coverage for ED | PAH may be subsidised under specific pathways |
Checklist for safe online purchase: buy from registered Australian pharmacies, verify product packaging and batch numbers, ensure a valid prescription source, and consult your pharmacist about unexpected price differences.
Comparable Medicines And Patient Preference Checklist — Sildenafil, Vardenafil, Avanafil
Patients often want to know how tadalafil compares with alternatives.
Sildenafil and vardenafil generally have a faster onset but a shorter duration of action than tadalafil.
Tadalafil’s distinguishing features are its long duration (up to 36 hours) and the option for daily low‑dose regimens that also benefit BPH symptoms.
Avanafil is faster in onset for some patients and can be better tolerated in others.
Use the following checklist to match medicine to patient preference and clinical context:
- Need for fast onset versus long window of effect.
- Frequency of sexual activity (daily activity may suit tadalafil daily dosing).
- Comorbidities and interactions, especially nitrates and strong CYP3A4 inhibitors.
- Side‑effect sensitivity (visual issues are more commonly reported with sildenafil).
- Cost and PBS coverage considerations.
| Drug | Onset | Duration | Indications | PBS Coverage (Typical) |
|---|---|---|---|---|
| Tadalafil | Slower onset than sildenafil; sustained effect | Up to 36 hours | ED, BPH, PAH (Adcirca) | Limited for ED; PAH pathways possible |
| Sildenafil | Faster onset | Shorter window | ED, PAH (Revatio) | Limited for ED; PAH pathways possible |
| Avanafil | Rapid onset | Intermediate duration | ED | Typically private prescription |
FAQ
Can I get tadalafil on the PBS?
PBS subsidisation for tadalafil is restricted; PAH indications using Adcirca and some specialist pathways may be covered, while most ED prescriptions are private.
Is Megalis the same as Cialis?
Both contain tadalafil as the active ingredient, but Megalis is a generic by Macleods and Cialis is the Eli Lilly brand; therapeutic effect should be equivalent when products are quality‑assured.
Can I buy tadalafil online without seeing a GP?
You need a valid prescription to legally obtain tadalafil in Australia, but telehealth services can provide an e‑prescription after assessment and link you to registered pharmacies.
Is it safe with alcohol and other medicines?
Avoid heavy drinking around dosing and never mix tadalafil with nitrates; always tell your prescriber and pharmacist about prescription, over‑the‑counter and herbal medicines.
| Question | Short Answer |
|---|---|
| PBS Access | Limited; check PBS online and discuss with your pharmacist |
| Megalis vs Cialis | Same INN (tadalafil); different manufacturers and excipients |
| Online Purchase | Requires prescription; use reputable Australian telehealth and pharmacies |
| Alcohol/Drug Safety | Avoid heavy alcohol; avoid nitrates; check interactions |
Guidelines For Proper Use And Pharmacist Counselling — Australian Best Practice
Pharmacists need a practical counselling checklist they can use every time.
- Confirm the indication and that the patient is an adult.
- Review cardiovascular history and current use of nitrates or potent CYP3A4 inhibitors.
- Reconcile medications using My Health Record or telehealth notes where available.
- Explain dosing options: on‑demand versus daily low dose, and prescribe accordingly.
- Discuss common side effects and clear urgent warning signs: priapism, sudden vision or hearing loss.
- Advise storage at 15–30°C in original packaging and keep out of reach of children.
- Document consent, encourage follow‑up for efficacy and tolerance, and report adverse events to the TGA DAEN.
For remote or Indigenous clients use culturally appropriate language, offer private consultation space and arrange clear local emergency plans if needed.
Sample pharmacist script for telehealth pick‑up: “This medication contains tadalafil; take one 10–20 mg tablet up to once daily before sexual activity or ask your prescriber about a daily 2.5–5 mg option if you prefer spontaneity. Avoid nitrates and heavy alcohol. If you get an erection lasting more than four hours or sudden vision/hearing changes, seek urgent care. Store between 15 and 30 degrees Celsius and bring all medicines to your GP or follow‑up.”
Delivery Across Australia
| City | Region | Delivery Time |
|---|---|---|
| Sydney | New South Wales | 5-7 days |
| Melbourne | Victoria | 5-7 days |
| Brisbane | Queensland | 5-7 days |
| Perth | Western Australia | 5-7 days |
| Adelaide | South Australia | 5-7 days |
| Canberra | Australian Capital Territory | 5-7 days |
| Hobart | Tasmania | 5-9 days |
| Darwin | Northern Territory | 5-9 days |
| Gold Coast | Queensland | 5-7 days |
| Newcastle | New South Wales | 5-7 days |
| Wollongong | New South Wales | 5-7 days |
| Geelong | Victoria | 5-7 days |
| Cairns | Queensland | 5-9 days |